1. Home
  2. OMEX vs ALXO Comparison

OMEX vs ALXO Comparison

Compare OMEX & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Odyssey Marine Exploration Inc.

OMEX

Odyssey Marine Exploration Inc.

HOLD

Current Price

$1.39

Market Cap

84.2M

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$2.18

Market Cap

68.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMEX
ALXO
Founded
1986
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.2M
68.3M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
OMEX
ALXO
Price
$1.39
$2.18
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.00
AVG Volume (30 Days)
433.3K
677.6K
Earning Date
03-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.36
EPS
N/A
N/A
Revenue
$9,327.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.41
52 Week High
$4.43
$2.66

Technical Indicators

Market Signals
Indicator
OMEX
ALXO
Relative Strength Index (RSI) 35.85 51.45
Support Level $1.25 $2.01
Resistance Level $1.75 $2.31
Average True Range (ATR) 0.11 0.17
MACD -0.00 -0.03
Stochastic Oscillator 11.11 43.94

Price Performance

Historical Comparison
OMEX
ALXO

About OMEX Odyssey Marine Exploration Inc.

Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodules (battery metals) projects. Its projects include the ExO Phosphate project, CIC, Ocean Minerals, and the LIHIR Gold project.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: